12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga·04/10/2026 17:05:53
Listen to the news
Gainers
Cue Biopharma (NASDAQ:CUE) shares increased by 69.9% to $0.5 during Friday's regular session. The company's market cap stands at $28.6 million.
Plus Therapeutics (NASDAQ:PSTV) shares moved upwards by 32.14% to $5.18. The company's market cap stands at $26.8 million.
Tempest Therapeutics (NASDAQ:TPST) shares rose 30.37% to $2.06. The company's market cap stands at $22.6 million.
Zentalis Pharmaceuticals (NASDAQ:ZNTL) stock rose 29.61% to $5.73. The market value of their outstanding shares is at $313.5 million.
Treace Medical Concepts (NASDAQ:TMCI) shares moved upwards by 20.58% to $1.84. The market value of their outstanding shares is at $97.4 million.
Organon (NYSE:OGN) stock moved upwards by 20.47% to $8.32. The market value of their outstanding shares is at $1.7 billion.
Losers
CDT Equity (NASDAQ:CDT) shares declined by 23.8% to $4.49 during Friday's regular session. The market value of their outstanding shares is at $27.8 million.
Replimune Group (NASDAQ:REPL) stock declined by 19.46% to $4.76. The market value of their outstanding shares is at $463.6 million.
Harvard Bioscience (NASDAQ:HBIO) stock fell 16.39% to $4.49. The company's market cap stands at $24.0 million.
Insight Molecular (NASDAQ:IMDX) stock declined by 16.2% to $2.67. The company's market cap stands at $102.2 million.
Profusa (NASDAQ:PFSA) shares decreased by 16.09% to $0.88. The company's market cap stands at $1.4 million.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.